title: Phospholipid metabolism modulates cyclic nucleotide phosphodiesterase activity in rat heart microsomes.
abstract: Cyclic nucleotide phosphodiesterase activity in rat heart microsomes is attributable to several isoenzymatic forms: a cyclic AMP-specific, a cyclic GMP-specific, and a cyclic GMP-stimulated enzyme. Incubation of microsomes with an exogenous phospholipase C (C. welchii) induced a marked stimulation (+126%) of cyclic AMP phosphodiesterase and a moderate stimulation (+49%) of cyclic GMP-phosphodiesterase in the membrane-bound fraction. Besides, a notable fraction of activity was solubilized by the treatment. A parallel decrease in the activating effect of cyclic GMP on the hydrolysis of cyclic AMP was observed in the membranes (down to 18% of the control effect). It resulted from a marked stimulation of the basal activity, while the activated level was unaffected. The treatment by an exogenous phospholipase D induced more moderate modifications. The addition to microsomes of oleyl,acetyl-glycerol, but not of long chain-diacylglycerols, partly reproduced the phospholipase C effect. Phosphatidate also induced variations in phosphodiesterase activity, and could thus participate in the phospholipase effects. These results suggest that endogenous phospholipases, the activity of which is modulated by hormonal stimuli, might influence phosphodiesterase activity in cardiac membranes by producing phospholipid metabolites, with potential consequences on heart contractility.
authors.affiliation: INSERM Unité 205, Institut National des Sciences Appliquées, Villeurbanne, France.
authors.forename: M
authors.initials: M
authors.lastname: Dubois
authors.forename: G
authors.initials: G
authors.lastname: Némoz
authors.forename: M
authors.initials: M
authors.lastname: Lagarde
authors.forename: A F
authors.initials: AF
authors.lastname: Prigent
mesh_terms: D000818:Animals; D002462:Cell Membrane / Q000201:enzymology / Q000378:metabolism; D004075:Diglycerides / Q000494:pharmacology; D008297:Male; D008861:Microsomes / Q000187:drug effects / Q000201:enzymology* / Q000378:metabolism; D009200:Myocardial Contraction; D009206:Myocardium / Q000201:enzymology* / Q000378:metabolism; D043264:Phosphodiesterase I; D010739:Phospholipase D / Q000494:pharmacology; D010743:Phospholipids / Q000378:metabolism*; D010727:Phosphoric Diester Hydrolases / Q000378:metabolism*; D051381:Rats; D011919:Rats, Inbred Strains; D010738:Type C Phospholipases / Q000494:pharmacology
chemical_list: D004075:Diglycerides; D010743:Phospholipids; C038237:1-oleoyl-2-acetylglycerol; D010727:Phosphoric Diester Hydrolases; D010738:Type C Phospholipases; D043264:Phosphodiesterase I; D010739:Phospholipase D